Factbox: Bundibugyo Ebola vaccines and treatments in development (devdiscourse.com)

• Existing Zaire Ebola tools ineffective against Bundibugyo
• Modified rVSV-ZEBOV and novel mAbs in pipeline
• CEPI and WHO funding accelerated development

"An operational overview of the R&D landscape confirms that current Zaire-specific tools like Ervebo and Inmazeb lack proven efficacy against the Bundibugyo strain, necessitating the prioritization of alternative candidates."